BioAge Labs to Present Preclinical Data on APJ Agonism for Diabetic Obesity and Heart Failure at the American Diabetes Association (ADA) 85th Scientific Sessions
June 21, 2025 18:00 ET Â | Source: BioAge Labs, Inc. Treatment with…
AVEROA receives European marketing authorization for XOANACYL, an Oral Therapy for Chronic Kidney Disease (CKD)
XOANACYL is an oral therapy designed to address critical challenges in CKD,…
RadioMedix Debuts Proprietary bench top Pb Generator to Support Targeted Alpha Therapy Development
New bench top ²¹²Pb generator to expand clinical-grade isotope supply for targeted…
KFSHRC First in the Middle East to Implant AI-Powered Brain-Sensing Device for Treating Neurological Disorders
RIYADH, Saudi Arabia, June 11, 2025 (GLOBE NEWSWIRE) -- In a landmark…
Wysa Launches AI-Powered Chatbot to Streamline Mental Health Patient Intake in the US
Automated screening cuts patient assessment time by 30 minutes in real-world useBOSTON--(BUSINESS…
Jopari and Raintree Formalize Partnership to Expand Access to Electronic Commercial Attachment Solutions
CONCORD, Calif.--(BUSINESS WIRE)--Raintree Systems, a leading provider of native-built AI-powered electronic health…
PeterMD Announces Official Website Update Featuring Telemedicine Services for Men’s Hormone Health and TRT Support
VERO BEACH, June 10, 2025 (GLOBE NEWSWIRE) -- PeterMD, a Florida-based men's…
World’s Leading Institutions and IBA launch Proton Therapy Academy to shape the future of cancer care
New global education initiative unveiled at 2025 PTCOG Annual Conference Louvain-la-Neuve, Belgium,…
Roches Tecentriq combined with lurbinectedin shows significant survival benefit in extensive-stage small cell lung cancer
46% reduction in the risk of disease progression or death, and 27%…
Novartis Pluvicto demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-positive metastatic hormone-sensitive prostate cancer
Ad hoc announcement pursuant to Art. 53 LR At interim analysis, PSMAddition…